KRIBIOLISAâ„¢ Anti-Infliximab (REMICADE) ELISA
KRISHGEN BioSystemsEnzyme Immunoassay for the quantitative determination of Anti-Infliximab antibodies in human serum and plasma.
Diagnostic Tests/Kits
Enzyme Immunoassay for the quantitative determination of Anti-Infliximab antibodies in human serum and plasma.
Is it COVID-19? Is it Flu? Lab-comparable results in minutes. Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results in 12 mins for patients suspected of Flu and/or COVID-19, to help decision making and guide treatment.
Is it RSV? Is it COVID-19? Actionable results in minutes. Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.
Our unique combination of custom antibody development, lateral flow development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.
BBI Solutions’ Novarum™ technology transforms a smartphone into a mobile diagnostic platform, empowering users to read and share the results of rapid tests at the point of care.
The InviRapid ® lateral flow test strips provide a fast and easy detection of diverse allergens within just a few minutes. These assays are suitable for on-site analysis, and do not require any laboratory equipment. They are user-friendly, even for inexperienced personnel, and can be applied in all stages of the food production process - from testing raw materials to finished good samples, and as part of the surface cleaning…
Opal 6-Plex Detection Kits - for Whole Slide Imaging (formerly Opal Polaris 7 Color IHC Detection Kits)
Determination of total anti-infliximab antibodies Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The protein can induce humoral immune responses and lead to anti-drug antibody formation, a major cause of loss of drug response. IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.
Determination of total anti-adalimumab antibodies Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating dru…
Sample Type:Serum; Sample Size:50 µl; Size:96 Wells (LIA); ange:0.25 - 50 ng/ml; Sensitivity:0.1 ng/ml; Incubation Time:30 minutes